Reports for RANBAXY PHARMACEUTICALS CANADA INC.

Company Name

RANBAXY PHARMACEUTICALS CANADA INC.

Totals

Shortage reports

72

Actual shortage: 4 (6%)
Anticipated shortage: 0 (0%)
Avoided shortage: 0 (0%)
Resolved: 68 (94%)

Discontinuation Reports

32

To be discontinued: 0 (0%)
Discontinued: 32 (100%)
Reversed: 0 (0%)

Late reports

47 (45%)

Overdue reports

4 (100%)

Showing 141 to 72 of 72

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
RAN-LISINOPRIL 5MG TABLET Discontinued 2021-12-07 2021-12-07 150671
RAN-LISINOPRIL 20MG TABLET Discontinued 2021-12-07 2021-12-07 150674
RAN-GABAPENTIN 100MG CAPSULE Discontinued 2019-03-29 2019-03-29 80048
RAN-GABAPENTIN 400MG CAPSULE Discontinued 2019-03-29 2019-03-29 80051
RAN-FENTANYL MATRIX PATCH 75MCG PATCH Discontinued 2019-03-29 2019-03-30 80022
RAN-FENTANYL MATRIX PATCH 50MCG PATCH Discontinued 2019-03-29 2019-03-29 80054
RAN-FENTANYL MATRIX PATCH 25MCG PATCH Discontinued 2019-07-15 2019-07-15 89250
RAN-FENTANYL MATRIX PATCH 100MCG PATCH Discontinued 2019-07-15 2019-07-15 89253
RAN-FENTANYL MATRIX PATCH 12MCG PATCH Discontinued 2019-09-03 2019-09-03 92856
RAN-CITALO 40MG TABLET Discontinued 2019-03-29 2019-03-29 80045
RAN-CITALO 20MG TABLET Discontinued 2020-03-07 2020-03-07 108124
RAN-CITALO 20MG TABLET Discontinued 2020-03-07 2020-03-07 108127

Showing 21 to 32 of 32